Across TCGA pan-cancer cohorts, ANKRD62P1-PARP4P3 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of ANKRD62P1-PARP4P3’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where ANKRD62P1-PARP4P3 RNA is repressed in tumor relative to normal tissue. In most cancer types ANKRD62P1-PARP4P3 is over-expressed in tumor, although a few such as KIRC and UCEC show the opposite, repressed pattern.

KIRC, UCEC, and KIRP are the cancer types where ANKRD62P1-PARP4P3 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ANKRD62P1-PARP4P3 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	IV	−0.142	<.001	11	view →
UCEC	All	All	−0.079	.001	6	view →
KIRP	Male	III,IV	−0.146	.007	2	view →
ESCA	All	All	−0.067	.013	2	view →
LUSC	Male	II,III,IV	−0.032	.007	2	view →
LUAD	All	All	+0.060	.037	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

Exploration

Same gene, other analysis: ANKRD62P1-PARP4P3 RNA expression & survival · all ANKRD62P1-PARP4P3 data types